HomeGLENMARK • NSE
add
Glenmark Pharmaceuticals Ltd
Previous close
₹1,080.30
Day range
₹1,061.25 - ₹1,088.75
Year range
₹516.25 - ₹1,096.00
Market cap
304.79B INR
Avg Volume
685.57K
P/E ratio
-
Dividend yield
0.23%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 25.07B | -27.63% |
Operating expense | 18.30B | -0.52% |
Net income | -3.51B | -228.91% |
Net profit margin | -14.02 | -278.14% |
Earnings per share | — | — |
EBITDA | -2.83B | -159.45% |
Effective tax rate | 13.77% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.24B | -9.36% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 97.36B | — |
Shares outstanding | 282.23M | — |
Price to book | 3.27 | — |
Return on assets | — | — |
Return on capital | -5.96% | — |
Cash Flow
Net change in cash
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.51B | -228.91% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India. Wikipedia
Founded
1977
Website
Employees
15,556